Table I.
Studies | Age (years) | Sex | Characteristic initial symptoms | Intubation from admission (days) | Intubation management (days) | IVIg treatment | mPSL treatment | Outcomes | Refs. |
---|---|---|---|---|---|---|---|---|---|
Kawai et al | 2 | Male | Expectoration difficulty, hoarseness | Nd | 8 | + | Nd | Extubation and discharge | (16) |
Minamihara et al | 3 | Female | Swallowing difficulty, hoarseness | 2 | 18 | + | + | Extubation and discharge on day 58 | (17) |
Takeshita et al | 4 | Male | Expectoration difficulty, dysphonia | Nd | 16 | + | Nd | Extubation and discharge on day 75 | (18) |
Shibata et al | 8 | Male | Breathing difficulty | 2 | 5 | + | Nd | Extubation and discharge | (19) |
Arashin et al | 10 | Female | Shallow breathing | 2 | Nd | Nd | Nd | Extubation and discharge | (20) |
Yata et al | 10 | Male | Diplopia, gait disturbance | Nd | Nd | + | Nd | Immunosorbent therapy, extubation, and discharge | (21) |
Kawai and Shimizu | 11 | Female | Bulbar palsy | Nd | Nd | + | Nd | Adenovirus infection, extubation, and discharge | (22) |
Present study | 12 | Male | Expectoration difficulty, breathing difficulty | 4 | 15 | + | + | 15 days after tracheotomy, breathing had improved and the hole was closed |
GBS, Guillain-Barré syndrome; IVIg, intravenous immunoglobulin; mPSL, methylprednisolone pulse; Nd, not described.